Search

everythinglearnresearchcommunity

for

Search:↓

New therapies for Birt–Hogg–Dubé syndrome are being developed based on understanding the FLCN gene's role.

New methods using biomaterials, stem cells, and nanoparticles show promise for improving hair growth and treating hair loss.

Nanoparticles improve skin treatment but need more research on safety and effectiveness.

GSH-T levels in hair follicles are similar in smokers and non-smokers and don't increase with certain treatments.

Astaxanthin may reduce inflammation in women with PCOS, but doesn't significantly improve symptoms.

Laser hair removal is effective and safe for reducing facial hair in women with PCOS and improves their psychological well-being.

Yoga helps manage PCOS symptoms and improves overall health.

Evaluate and manage androgen excess in women with a systematic approach, considering both physical and psychological impacts.

PCOS women have more severe metabolic issues and higher androgen levels than hyperandrogenic women without PCOS.

Hormonal imbalances can cause acne, excess hair growth, and hair loss in women, needing combined medical and emotional care.

Hormonal imbalances in women can cause acne, excess hair growth, and hair loss, needing combined medical and mental health care.

Hormonal imbalances in women can cause acne, excess hair growth, and hair loss, needing combined medical and mental health care.

miR-155-5p can help diagnose and track alopecia areata severity.

Nanotechnology shows promise for better hair loss treatments but needs more research for safety and effectiveness.

Insulin resistance and hyperinsulinism are linked to fertility issues and can worsen symptoms of PCOS.

Air pollution harms skin health and can worsen skin diseases.

Hair analysis shows infants and mothers in north-western Spain are exposed to environmental pollutants, with factors like diet and residence affecting pollutant levels.

Women with PCOS often experience depression and anxiety, affecting their quality of life.

GLP-1 receptor agonists, like Dulaglutide, Liraglutide, and Semaglutide, have potential benefits beyond the pancreas, including neuroprotection, pain suppression, cardiovascular protection, obesity management, and cancer treatment, but there are concerns about pancreatitis and pancreatic cancer risks.

The document says that hirsutism in women usually needs hair removal and hormone treatment to manage symptoms and improve well-being.

The roadmap calls for better research and funding to improve PCOS diagnosis, treatment, and health outcomes.

The document concludes that a systematic approach is crucial to identify causes of androgen excess in women beyond the most common cause, Polycystic ovary syndrome (PCOS).

Significant progress was made in understanding androgen excess disorders, but much is still unknown.

Paxillin may help manage androgen-related disorders like PCOS by stabilizing androgen receptor proteins.

Nutraceutical insulin-sensitizing agents may help treat skin conditions like psoriasis and acne.

Hirsutism in GCC countries is influenced by genetics, obesity, and lifestyle, with cultural stigma delaying treatment, highlighting the need for tailored health strategies.

Middle-aged women with PCOS often continue to experience symptoms related to high androgen levels, like unwanted hair growth.

Early baldness in men may indicate risks for obesity, metabolic syndrome, insulin resistance, and heart disease, similar to women with PCOS. Alopecia areata is often linked with autoimmune diseases and mental health issues. Certain hair disorders are due to genetic issues, and chemotherapy can cause hair loss through specific biological pathways. Iron deficiency's link to hair loss is still disputed.

Addressing body image and weight can help improve female sexual dysfunction.

Severe hair loss may increase the risk of dying from COVID-19.